Public reporting on pharmaceutical industry-led access programs: Alignment with the WHO medicine programs evaluation checklist
dc.contributor.author | Laing, Richard O. | |
dc.contributor.author | Umeh, Chukwuemeka Anthony | |
dc.contributor.author | Rockers, Peter C. | |
dc.date.accessioned | 2020-12-15T08:10:50Z | |
dc.date.available | 2020-12-15T08:10:50Z | |
dc.date.issued | 2020 | |
dc.description.abstract | There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organization (WHO) medicine program checklist as a framework for public reporting and assessing of programs. | en_US |
dc.identifier.citation | 10. Laing, R. O. et al. (2020). Public reporting on pharmaceutical industry-led access programs: Alignment with the WHO medicine programs evaluation checklist. Journal of Pharmaceutical Policy and Practice ,13(1),5 | en_US |
dc.identifier.issn | 2052-3211 | |
dc.identifier.uri | https://doi.org/10.1186/s40545-020-0204-z | |
dc.identifier.uri | http://hdl.handle.net/10566/5515 | |
dc.language.iso | en | en_US |
dc.publisher | Springer Nature | en_US |
dc.subject | Medicines | en_US |
dc.subject | Access | en_US |
dc.subject | Industry | en_US |
dc.subject | Private sector | en_US |
dc.subject | Transparency | en_US |
dc.title | Public reporting on pharmaceutical industry-led access programs: Alignment with the WHO medicine programs evaluation checklist | en_US |
dc.type | Article | en_US |